$ARWR
ARROWHEAD PHARMACEUTICALS, INC.

2020 Q3 Form 10-K Financial Statement

#000156459020054893 Filed on November 23, 2020

View on sec.gov

Income Statement

Concept 2020 Q3 2020 Q2 2020 Q1
Revenue $7.633M $27.38M $23.53M
YoY Change -82.37% -35.88% -51.13%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $14.11M $10.59M $16.17M
YoY Change 37.39% 120.17% 202.81%
% of Gross Profit
Research & Development $41.86M $32.57M $28.22M
YoY Change 78.97% 68.85% 35.67%
% of Gross Profit
Depreciation & Amortization $1.700M $1.100M $900.0K
YoY Change 70.0% 90.2% 19.86%
% of Gross Profit
Operating Expenses $57.75M $32.57M $45.77M
YoY Change 71.62% 35.15% 75.1%
Operating Profit -$50.12M -$15.95M -$22.24M
YoY Change -620.01% -185.75% -201.04%
Interest Expense $2.270M $2.330M $2.400M
YoY Change 1.34% 33.91% 26.98%
% of Operating Profit
Other Income/Expense, Net -$580.0K
YoY Change
Pretax Income -$48.43M -$13.61M -$19.84M
YoY Change -507.66% -166.93% -183.01%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$48.43M -$13.61M -$19.84M
YoY Change -513.78% -166.93% -183.01%
Net Earnings / Revenue -634.53% -49.72% -84.31%
Basic Earnings Per Share -$0.48 -$0.13 -$0.20
Diluted Earnings Per Share -$0.48 -$0.13 -$0.20
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2020 Q3 2020 Q2 2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $228.6M $287.0M $307.6M
YoY Change -11.64% 21.15% 40.97%
Cash & Equivalents $143.6M $219.3M $256.7M
Short-Term Investments $85.00M $67.70M $51.00M
Other Short-Term Assets $1.782M $6.500M $5.600M
YoY Change -30.48% 335.61% 64.71%
Inventory
Prepaid Expenses $4.251M
Receivables $846.0K $21.70M $1.300M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $322.4M $315.2M $314.5M
YoY Change 21.54% 28.9% 33.83%
LONG-TERM ASSETS
Property, Plant & Equipment $30.88M $30.39M $29.36M
YoY Change 33.02% 77.98% 119.12%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $137.5M $177.5M $190.6M
YoY Change 211.09% 208.16% 182.37%
Other Assets $264.0K $300.0K $100.0K
YoY Change 83.15% 50.0% 0.0%
Total Long-Term Assets $200.1M $240.5M $246.6M
YoY Change 136.57% 160.67% 149.34%
TOTAL ASSETS
Total Short-Term Assets $322.4M $315.2M $314.5M
Total Long-Term Assets $200.1M $240.5M $246.6M
Total Assets $522.5M $555.7M $561.1M
YoY Change 49.35% 64.99% 68.04%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $6.829M $4.100M $13.40M
YoY Change -10.73% -10.87% 226.83%
Accrued Expenses $5.389M $12.40M $6.700M
YoY Change -17.15% 87.88% 0.0%
Deferred Revenue $19.29M
YoY Change -75.19%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $40.68M $42.80M $53.30M
YoY Change -58.09% -50.85% -47.64%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $20.00M $20.40M $14.20M
YoY Change 129.89% -15.35% -54.92%
Total Long-Term Liabilities $20.04M $20.40M $14.20M
YoY Change 129.36% -15.25% -54.92%
TOTAL LIABILITIES
Total Short-Term Liabilities $40.68M $42.80M $53.30M
Total Long-Term Liabilities $20.04M $20.40M $14.20M
Total Liabilities $60.73M $62.60M $67.00M
YoY Change -42.61% -43.68% -49.51%
SHAREHOLDERS EQUITY
Retained Earnings -$503.8M
YoY Change 20.17%
Common Stock $965.6M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $461.8M $493.1M $494.1M
YoY Change
Total Liabilities & Shareholders Equity $522.5M $555.7M $561.1M
YoY Change 49.35% 64.98% 68.04%

Cashflow Statement

Concept 2020 Q3 2020 Q2 2020 Q1
OPERATING ACTIVITIES
Net Income -$48.43M -$13.61M -$19.84M
YoY Change -513.78% -166.93% -183.01%
Depreciation, Depletion And Amortization $1.700M $1.100M $900.0K
YoY Change 70.0% 90.2% 19.86%
Cash From Operating Activities -$10.90M -$33.40M -$27.60M
YoY Change -178.99% -418.1% 40.82%
INVESTING ACTIVITIES
Capital Expenditures -$1.900M -$2.200M -$3.600M
YoY Change -75.64% -33.33% 1700.0%
Acquisitions
YoY Change
Other Investing Activities -$64.00M -$3.900M -$174.5M
YoY Change -359.11% -122.16% 1486.36%
Cash From Investing Activities -$65.90M -$6.100M -$178.1M
YoY Change -489.94% -142.36% 1490.18%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.000M 2.100M 1.300M
YoY Change -47.37% -22.22% -51.85%
NET CHANGE
Cash From Operating Activities -10.90M -33.40M -27.60M
Cash From Investing Activities -65.90M -6.100M -178.1M
Cash From Financing Activities 1.000M 2.100M 1.300M
Net Change In Cash -75.80M -37.40M -204.4M
YoY Change -332.52% -235.51% 627.4%
FREE CASH FLOW
Cash From Operating Activities -$10.90M -$33.40M -$27.60M
Capital Expenditures -$1.900M -$2.200M -$3.600M
Free Cash Flow -$9.000M -$31.20M -$24.00M
YoY Change -141.67% -326.09% 23.71%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020 us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
arwr:TechnologyLicensesCollaborativeResearchAndDevelopmentArrangementsResearchGrantsAndProductSalesMember
CY2020Q3 us-gaap Held To Maturity Securities Current
HeldToMaturitySecuritiesCurrent
86889751
CY2020Q3 us-gaap Assets Current
AssetsCurrent
322370397
CY2020 dei Security12b Title
Security12bTitle
Common Stock, $0.001 par value
CY2020 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2020 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2020Q1 dei Entity Public Float
EntityPublicFloat
2900000000
CY2020Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
102756771
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
143582667
CY2020Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
845673
CY2020Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
4250896
CY2020Q3 us-gaap Other Assets Current
OtherAssetsCurrent
1781691
CY2020Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
30880868
CY2020Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
15363151
CY2019Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
8738506
CY2020Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
18433
CY2019Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-391624
CY2020 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
9190501
CY2018 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
1048523
CY2019 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
6957768
CY2019 us-gaap Operating Income Loss
OperatingIncomeLoss
61190634
CY2020 us-gaap Operating Expenses
OperatingExpenses
181150869
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
-93158803
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-54448078
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-84550826
CY2019 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.72
CY2020 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
8607977
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
68148402
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.84
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-84553226
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.84
CY2019 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
6957768
CY2019 us-gaap Profit Loss
ProfitLoss
67974849
CY2018 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
83638469
CY2018 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-54796
CY2019 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
98607815
CY2018 us-gaap Profit Loss
ProfitLoss
-54450478
CY2020 us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
-525305
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
100722224
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
43382988
CY2018 us-gaap Net Income Loss
NetIncomeLoss
-54450478
CY2018 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.65
CY2018 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
7493
CY2019Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
661361
CY2019Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
3317999
CY2020 dei Entity Shell Company
EntityShellCompany
false
CY2019Q3 us-gaap Other Assets Current
OtherAssetsCurrent
2563435
CY2019Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
221804128
CY2018 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1488157
CY2019 us-gaap Net Income Loss
NetIncomeLoss
67974849
CY2018 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.65
CY2020 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-582524
CY2019 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
93858857
CY2020Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2019 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
81048686
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
100722224
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
87992066
CY2020 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-84143169
CY2020 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
128874979
CY2020Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
145000000
CY2020Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
102376303
CY2020Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
102376303
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2400
CY2019 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
168795577
CY2018 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1016506
CY2019 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
1104963
CY2018 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-414293
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-95391570
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
173034923
CY2020 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
11951712
CY2019Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
244036252
CY2019 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.69
CY2018 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
19110051
CY2020 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
410057
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.004
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0150
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0205
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y3M
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y3M
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y3M
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.018
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0311
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0299
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.90
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.92
CY2019Q4 us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
arwr:TechnologyLicensesCollaborativeResearchAndDevelopmentArrangementsResearchGrantsAndProductSalesMember
CY2020Q1 us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
arwr:TechnologyLicensesCollaborativeResearchAndDevelopmentArrangementsResearchGrantsAndProductSalesMember
CY2020Q2 us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
arwr:TechnologyLicensesCollaborativeResearchAndDevelopmentArrangementsResearchGrantsAndProductSalesMember
CY2020Q3 us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
arwr:TechnologyLicensesCollaborativeResearchAndDevelopmentArrangementsResearchGrantsAndProductSalesMember
CY2018Q4 us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
arwr:TechnologyLicensesCollaborativeResearchAndDevelopmentArrangementsResearchGrantsAndProductSalesMember
CY2019Q1 us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
arwr:TechnologyLicensesCollaborativeResearchAndDevelopmentArrangementsResearchGrantsAndProductSalesMember
CY2019Q2 us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
arwr:TechnologyLicensesCollaborativeResearchAndDevelopmentArrangementsResearchGrantsAndProductSalesMember
CY2019Q3 us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
arwr:TechnologyLicensesCollaborativeResearchAndDevelopmentArrangementsResearchGrantsAndProductSalesMember
CY2020 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2020Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
85019719
CY2019Q3 us-gaap Held To Maturity Securities Current
HeldToMaturitySecuritiesCurrent
36899894
CY2019Q3 us-gaap Assets Current
AssetsCurrent
265246817
CY2019Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
23214899
CY2019Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
17063580
CY2020Q3 us-gaap Held To Maturity Securities Noncurrent
HeldToMaturitySecuritiesNoncurrent
137486883
CY2019Q3 us-gaap Held To Maturity Securities Noncurrent
HeldToMaturitySecuritiesNoncurrent
44175993
CY2020Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
16137085
CY2020Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
265359
CY2020Q3 arwr Equity Securities Fvni Accumulated Gross Unrealized Loss Before Tax
EquitySecuritiesFVNIAccumulatedGrossUnrealizedLossBeforeTax
75015
CY2018 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
52083131
CY2019 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
54521219
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-240777764
CY2019 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-47746007
CY2018 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
83638469
CY2018 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-54505274
CY2019Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
144148
CY2020Q3 us-gaap Assets
Assets
522503743
CY2019Q3 us-gaap Assets
Assets
349845437
CY2020Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
6828909
CY2018 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
432141
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
173553
CY2019 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
67604789
CY2017Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
80867162
CY2018 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
8454607
CY2018 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2656710
CY2018 arwr Stock Issued During Period Value Exercise Of Warrants
StockIssuedDuringPeriodValueExerciseOfWarrants
1237429
CY2018Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
95241001
CY2019 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
12393323
CY2019Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
7649921
CY2020Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5388556
CY2019Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
6504729
CY2020Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
8060854
CY2019Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
4955887
CY2020Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1094777
CY2019Q3 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
173952
CY2020Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
19291075
CY2019Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
77769629
CY2020Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
17262
CY2019Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
16561
CY2020Q3 us-gaap Liabilities Current
LiabilitiesCurrent
40681433
CY2019Q3 us-gaap Liabilities Current
LiabilitiesCurrent
97070679
CY2020Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
20043178
CY2019Q3 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
3703364
CY2019Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
5035142
CY2019 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
8275410
CY2019 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
60521729
CY2019 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-370060
CY2019Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
244036252
CY2020 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
43382988
CY2020 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
250478974
CY2020 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
410057
CY2020 us-gaap Noncontrolling Interest Decrease From Deconsolidation
NoncontrollingInterestDecreaseFromDeconsolidation
555188
CY2020 us-gaap Profit Loss
ProfitLoss
-84553226
CY2020 us-gaap Profit Loss
ProfitLoss
-84553226
CY2018 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
432141
CY2018Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.13
CY2019Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-419290967
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
244591440
CY2018 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
16142321
CY2018 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
52968505
CY2018 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2400
CY2018 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
-54668
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
143582667
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
221804128
CY2018Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
30133213
CY2018 us-gaap Interest Paid Net
InterestPaidNet
173381
CY2018 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
3631164
CY2019 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
60521739
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
257947873
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
66381999
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-78221461
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
221804128
CY2018Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
30133213
CY2019 us-gaap Share Based Compensation
ShareBasedCompensation
12393323
CY2018 us-gaap Share Based Compensation
ShareBasedCompensation
8454607
CY2020 us-gaap Depreciation And Amortization
DepreciationAndAmortization
5942264
CY2019 us-gaap Depreciation And Amortization
DepreciationAndAmortization
4439144
CY2018 us-gaap Depreciation And Amortization
DepreciationAndAmortization
4699275
CY2019 us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
-1069070
CY2018 us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
-383075
CY2020 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
184312
CY2019 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
333986
CY2018 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
259578
CY2020 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
387464
CY2019 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
3710515
CY2018 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-319166
CY2020 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-63513696
CY2019 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
82804171
CY2018 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-5269140
CY2019 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
4843825
CY2018 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1270416
CY2020 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1989496
CY2019 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
2450079
CY2020 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
2228087
CY2018 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-47223417
CY2019 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
12001225
CY2018 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1421252
CY2020 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
278964290
CY2019 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
90266001
CY2020 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
50138238
CY2018 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
46069420
CY2018 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-7434963
CY2019 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
2415150
CY2018 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
208506
CY2018 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
54667
CY2020 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
7468899
CY2019 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
8275410
CY2020 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
250478974
CY2018 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
56585035
CY2018 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
59953026
CY2019 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
191670915
CY2018 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
5294646
CY2017Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
24838567
CY2019 us-gaap Interest Paid Net
InterestPaidNet
27437
CY2020 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
103437
CY2019 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-302400
CY2018 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-2400
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
143600000
CY2020Q3 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
1800000
CY2020Q3 us-gaap Held To Maturity Securities Current
HeldToMaturitySecuritiesCurrent
86900000
CY2020Q3 us-gaap Marketable Securities
MarketableSecurities
85000000.0
CY2020Q3 us-gaap Held To Maturity Securities Noncurrent
HeldToMaturitySecuritiesNoncurrent
137500000
CY2020 arwr Increase Decrease In Cash And Investments
IncreaseDecreaseInCashAndInvestments
150100000
CY2020 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
279000000.0
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-95400000
CY2019Q4 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
250500000
CY2020 us-gaap Proceeds From Sale Maturity And Collection Of Longterm Investments
ProceedsFromSaleMaturityAndCollectionOfLongtermInvestments
50100000
CY2020Q3 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
1800000
CY2019Q3 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
1000000.0
CY2020 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Concentration of Credit Risk—The Company maintains several bank accounts primarily at two financial institutions for its operations. These accounts are insured by the Federal Deposit Insurance Corporation (FDIC) for up to $250,000 per institution. Management believes the Company is not exposed to significant credit risk due to the financial position of the depository institutions in which these deposits are held. </p>
CY2020Q3 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
0
CY2019Q3 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
0
CY2020 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0
CY2019 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
4748958
CY2018 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0
CY2019Q3 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Gain
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain
1097842
CY2020Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
16100000
CY2020Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
21100000
CY2020Q3 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
661927
CY2019Q3 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
637577
CY2020Q3 arwr Research Equipment Gross
ResearchEquipmentGross
20654323
CY2019Q3 arwr Research Equipment Gross
ResearchEquipmentGross
12932304
CY2020Q3 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
631204
CY2019Q3 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
147254
CY2020Q3 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
25237851
CY2019Q3 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
21579415
CY2020Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
47185305
CY2019Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
35296550
CY2020Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
16304437
CY2019Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
12081651
CY2020Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
30880868
CY2019Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
23214899
CY2020 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4241834
CY2019 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2738715
CY2018 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2998846
CY2020Q3 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
224376634
CY2020Q3 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Gain
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain
6163837
CY2020Q3 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Loss
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss
79471
CY2020Q3 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
230461000
CY2019Q3 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
81075887
CY2019Q3 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
82173729
CY2020Q3 us-gaap Equity Securities Fv Ni Cost
EquitySecuritiesFvNiCost
85000000
CY2020Q3 arwr Equity Securities Fvni Accumulated Gross Realized Gain Loss Before Tax
EquitySecuritiesFVNIAccumulatedGrossRealizedGainLossBeforeTax
94734
CY2020Q3 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
85019719
CY2020 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1700429
CY2019 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1700430
CY2018 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1700429
CY2020Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
1700429
CY2020Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
1700429
CY2020Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
1700429
CY2020Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
1700429
CY2020Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
1700429
CY2020Q3 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
6861006
CY2019Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
17063580
CY2020 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1700429
CY2020Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
15363151
CY2020Q3 us-gaap Capital Units Authorized
CapitalUnitsAuthorized
150000000
CY2020Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
145000000
CY2020Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2020Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2020Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
102376303
CY2020Q3 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
0
CY2020Q3 us-gaap Purchase Obligation
PurchaseObligation
78000000.0
CY2020Q3 us-gaap Purchase Obligation Due In Next Twelve Months
PurchaseObligationDueInNextTwelveMonths
60200000
CY2020Q3 us-gaap Purchase Obligation Due In Second Year
PurchaseObligationDueInSecondYear
17800000
CY2020 us-gaap Operating Lease Cost
OperatingLeaseCost
2400000
CY2019 us-gaap Operating Lease Cost
OperatingLeaseCost
1300000
CY2018 us-gaap Operating Lease Cost
OperatingLeaseCost
1300000
CY2020 us-gaap Variable Lease Cost
VariableLeaseCost
800000
CY2020 us-gaap Short Term Lease Cost
ShortTermLeaseCost
0
CY2019 us-gaap Short Term Lease Cost
ShortTermLeaseCost
0
CY2018 us-gaap Short Term Lease Cost
ShortTermLeaseCost
0
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
3091901
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
3853290
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
3406754
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
3269674
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
3358292
CY2020Q3 arwr Lessee Operating Lease Liability Payments Due Year Five And After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFiveAndAfterYearFive
15331296
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
32311207
CY2020Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
11173252
CY2020Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
21137955
CY2020 us-gaap Operating Lease Payments
OperatingLeasePayments
1800000
CY2019 us-gaap Operating Lease Payments
OperatingLeasePayments
1300000
CY2018 us-gaap Operating Lease Payments
OperatingLeasePayments
1300000
CY2020Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P9Y4M24D
CY2020Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.084
CY2019Q3 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
1521451
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
8.30
CY2019Q3 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
2256379
CY2019Q3 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
2521446
CY2019Q3 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
2590558
CY2019Q3 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
2661512
CY2019Q3 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
10834206
CY2019Q3 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
22385552
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4773670
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
8.16
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
951500
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
48.19
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
74639
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
22.38
CY2020 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
1111128
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
6.72
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4539403
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
16.67
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y2M12D
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
129100277
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
2924744
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y9M18D
CY2020Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
102698309
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.15
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.10
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
36.35
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
13.80
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
5.04
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Description
ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription
At vesting, each outstanding RSU will be exchanged for one share of the Company’s Common Stock. RSU recipients may elect to net share settle upon vesting, in which case the Company pays the employee’s income taxes due upon vesting and withholds a number of shares of Common Stock of equal value.  RSU awards generally vest subject to the satisfaction of service requirements or the satisfaction of both service requirements and achievement of certain performance targets.
CY2020Q3 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
2086396
CY2019Q3 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
1310466
CY2020Q3 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
10936819
CY2019Q3 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
3609756
CY2020Q3 arwr Deferred Tax Assets In Process Research And Development Cost
DeferredTaxAssetsInProcessResearchAndDevelopmentCost
624915
CY2019Q3 arwr Deferred Tax Assets In Process Research And Development Cost
DeferredTaxAssetsInProcessResearchAndDevelopmentCost
926026
CY2020Q3 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
0
CY2019Q3 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
0
CY2020Q3 us-gaap Deferred Tax Assets Tax Credit Carryforwards Alternative Minimum Tax
DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax
178652
CY2019Q3 us-gaap Deferred Tax Assets Tax Credit Carryforwards Alternative Minimum Tax
DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax
173553
CY2019Q3 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
438882
CY2020Q3 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
151007113
CY2019Q3 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
105372571
CY2020Q3 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
2818002
CY2019Q3 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
3590090
CY2020Q3 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
1702357
CY2020Q3 arwr Deferred Tax Assets Right Of Use Assets Or Lease Liabilities
DeferredTaxAssetsRightOfUseAssetsOrLeaseLiabilities
1015626
CY2019Q3 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Deferred Rent
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent
821317
CY2020Q3 us-gaap Deferred Tax Assets Capital Loss Carryforwards
DeferredTaxAssetsCapitalLossCarryforwards
709779
CY2019Q3 us-gaap Deferred Tax Assets Capital Loss Carryforwards
DeferredTaxAssetsCapitalLossCarryforwards
709779
CY2020Q3 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
171079659
CY2019Q3 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
116952440
CY2020Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
156603859
CY2019Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
108232402
CY2020Q3 arwr Deferred Tax Liabilities State Taxes
DeferredTaxLiabilitiesStateTaxes
11928832
CY2019Q3 arwr Deferred Tax Liabilities State Taxes
DeferredTaxLiabilitiesStateTaxes
8720038
CY2020Q3 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
14475800
CY2019Q3 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
8720038
CY2020Q3 arwr Percentage Of Valuation Allowance
PercentageOfValuationAllowance
1
CY2020Q3 arwr Federal Net Operating Loss Carry Forward
FederalNetOperatingLossCarryForward
473000000.0
CY2020Q3 arwr State Net Operating Loss Carry Forwards
StateNetOperatingLossCarryForwards
497000000.0
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2400
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
173553
CY2020 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2019 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2020 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.070
CY2019 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.073
CY2020 arwr Effective Income Tax Rate Reconciliation Deductions Stock Compensation Percent
EffectiveIncomeTaxRateReconciliationDeductionsStockCompensationPercent
-0.294
CY2019 arwr Effective Income Tax Rate Reconciliation Deductions Stock Compensation Percent
EffectiveIncomeTaxRateReconciliationDeductionsStockCompensationPercent
0.150
CY2020 arwr Effective Income Tax Rate Reconciliation Mark To Market Adjustments
EffectiveIncomeTaxRateReconciliationMarkToMarketAdjustments
0.000
CY2019 arwr Effective Income Tax Rate Reconciliation Mark To Market Adjustments
EffectiveIncomeTaxRateReconciliationMarkToMarketAdjustments
0.000
CY2020 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.574
CY2019 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.130
CY2020 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.000
CY2019 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.000
CY2020 arwr Effective Income Tax Rate Reconciliation True Up On Deferred Tax Rate
EffectiveIncomeTaxRateReconciliationTrueUpOnDeferredTaxRate
0.000
CY2019 arwr Effective Income Tax Rate Reconciliation True Up On Deferred Tax Rate
EffectiveIncomeTaxRateReconciliationTrueUpOnDeferredTaxRate
0.000
CY2020 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0.000
CY2019 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0.000
CY2020 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000
CY2019 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.003
CY2019Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.24
CY2019Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.21
CY2019Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.12
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-15945862
CY2020 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
863080
CY2019 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
545698
CY2018 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
451623
CY2019Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
29454579
CY2020Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
23528853
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
27375778
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7632856
CY2019Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-4853594
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-22240255
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-50119092
CY2019Q4 us-gaap Profit Loss
ProfitLoss
-2673728
CY2020Q1 us-gaap Profit Loss
ProfitLoss
-19835570
CY2020Q2 us-gaap Profit Loss
ProfitLoss
-13611213
CY2020Q3 us-gaap Profit Loss
ProfitLoss
-48432715
CY2019Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.20
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.13
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.48
CY2019Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.20
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.13
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.48
CY2018Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
34657896
CY2019Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
48148275
CY2019Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
42696636
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
43292770
CY2018Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
10946144
CY2019Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
22010692
CY2019Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
18595749
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
9638049
CY2018Q4 us-gaap Profit Loss
ProfitLoss
12037253
CY2019Q1 us-gaap Profit Loss
ProfitLoss
23896982
CY2019Q2 us-gaap Profit Loss
ProfitLoss
20335708
CY2019Q3 us-gaap Profit Loss
ProfitLoss
11704906
CY2018Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.13
CY2019Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.25
CY2019Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.21
CY2019Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.12

Files In Submission

Name View Source Status
0001564590-20-054893-index-headers.html Edgar Link pending
0001564590-20-054893-index.html Edgar Link pending
0001564590-20-054893.txt Edgar Link pending
0001564590-20-054893-xbrl.zip Edgar Link pending
arwr-10k_20200930.htm Edgar Link pending
arwr-10k_20200930_htm.xml Edgar Link completed
arwr-20200930.xsd Edgar Link pending
arwr-20200930_cal.xml Edgar Link unprocessable
arwr-20200930_def.xml Edgar Link unprocessable
arwr-20200930_lab.xml Edgar Link unprocessable
arwr-20200930_pre.xml Edgar Link unprocessable
arwr-ex1023_125.htm Edgar Link pending
arwr-ex1024_124.htm Edgar Link pending
arwr-ex1025_123.htm Edgar Link pending
arwr-ex1026_121.htm Edgar Link pending
arwr-ex1027_122.htm Edgar Link pending
arwr-ex21_669.htm Edgar Link pending
arwr-ex23_668.htm Edgar Link pending
arwr-ex311_7.htm Edgar Link pending
arwr-ex312_10.htm Edgar Link pending
arwr-ex321_6.htm Edgar Link pending
arwr-ex322_9.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
gd14pbv45bwf000001.jpg Edgar Link pending
gd14pbv45bwf000002.jpg Edgar Link pending
gd14pbv45bwf000003.jpg Edgar Link pending
gei541vqjlbv000001.jpg Edgar Link pending
gei541vqjlbv000002.jpg Edgar Link pending
gei541vqjlbv000003.jpg Edgar Link pending
gei541vqjlbv000004.jpg Edgar Link pending
gemzezolivjc000001.jpg Edgar Link pending
gemzezolivjc000002.jpg Edgar Link pending
gemzezolivjc000003.jpg Edgar Link pending
gemzezolivjc000004.jpg Edgar Link pending
ghp5h1w3ypdd000001.jpg Edgar Link pending
ghp5h1w3ypdd000002.jpg Edgar Link pending
gn51aow5g2rf000001.jpg Edgar Link pending
gn51aow5g2rf000002.jpg Edgar Link pending
gt1e50hnuuzf000001.jpg Edgar Link pending
gt1e50hnuuzf000002.jpg Edgar Link pending
gt1e50hnuuzf000003.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending